[Manifestations of Wegener granulomatosis of the ENT area? Differential diagnosis, therapy?].
Riemann
R
R
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005938:Glucocorticoids; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D010038:Otorhinolaryngologic Diseases / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D005938:Glucocorticoids
Frage: Welches Erscheinungsbild hat die Wegenersche Granulomatose im HNO-Bereich? Differenzialdiagnose, Therapie?